Product Information
ZIDOVUDINE 300 MG TABLET is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.4638 per EA under NDC 31722050960. Its NADAC has been published 544 times since Nov 28, 2013.
FDA first approved this application on Apr 25, 2008. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722050960
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
ZIDOVUDINEApproval Type
Generic (ANDA)
FDA Application
ANDA090092FDA Approved
4/25/2008
TE Code
AB
On Market Since
4/25/2008
Pharmacological Classes
Price Statistics
The NADAC for ZIDOVUDINE 300 MG TABLET has been published 544 times since Nov 28, 2013, and over the history we have for it it has risen 55.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4638 per EA |
|---|---|
| All-time high | $0.4991 (Dec 15, 2021) |
| All-time low | $0.2729 (Apr 23, 2014) |
| 52-week high | $0.4638 |
| 52-week low | $0.4016 |
| Median price | $0.4082 |
| Average price | $0.3961 |
| Largest weekly change | +41.0% (Dec 21, 2016) |
| Weeks tracked | 544 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 13% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of ZIDOVUDINE 300 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ZIDOVUDINE 300 MG TABLET, manufactured by Camber Pharmaceuticals Inc., is $0.4638 per EA (NDC 31722050960), effective Aug 19, 2026.
How has the price of ZIDOVUDINE 300 MG TABLET changed over time?
Over the history we have for it, the NADAC for ZIDOVUDINE 300 MG TABLET has risen 55.9%. It has been tracked across 544 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZIDOVUDINE 300 MG TABLET?
Since Nov 28, 2013, the NADAC for ZIDOVUDINE 300 MG TABLET has ranged from a low of $0.2729 (Apr 23, 2014) to a high of $0.4991 (Dec 15, 2021), with a median of $0.4082 per EA.
Are there cheaper alternatives to ZIDOVUDINE 300 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZIDOVUDINE 300 MG TABLET, is $0.4016 per EA — about 13% below ZIDOVUDINE 300 MG TABLET.
Who manufactures ZIDOVUDINE 300 MG TABLET?
ZIDOVUDINE 300 MG TABLET (NDC 31722050960) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.